2021/2022 revenue growth: +5%
New SaaS contracts 2021/2022: +17%
2021/2022 income: €84.5 million (+5%)
||Switch||12 months ended
Turnover for the year is in line with the forecasts communicated at the end of the 3rd quarter: it amounts to €84.5 million, up 5.3% compared to the previous year. Quarterly revenue for the fourth quarter amounted to 22.5 million euros, a new quarterly record for the Group.
SaaS activity grew strongly in the last quarter (+14%). As a result, software revenue grew 10% in the fourth quarter and 6% year-over-year.
As announced in previous press releases, the slowdown in the Services business in
New SaaS contracts: €5.5 M (+17%)
||Switch||12 months ended
|Signature of a new SaaS contract (ACV*)||1,821||2,217||-18%||5,539||4,746||17%|
* New signatures expressed in ACV (Annual Contract Value) highlighting the average annual additional revenue that will be generated after deployment of the contracts concerned.
The annual growth of new SaaS contracts is 17%, confirming the Group’s commercial momentum.
The evolution of SaaS signatures includes a negative base effect in the second half: the previous year, the health crisis had led to a slowdown in new SaaS signatures in the first half, followed by an acceleration in the second half.
Among these new signings:
Franceas part of a multi-year strategic partnership, Generic GroupThe Invoice Services solution was chosen by Pitney Bowes to be customized and marketed to its French customers, particularly as part of their digital transformation and more specifically for their regulatory compliance;
SpainLogikfred, a 3PL operator specializing in negative cold, one of the most demanding segments in the world of logistics, has chosen Generix Group’s Warehouse Management System (WMS), supplemented by the Yard Management System (YMS), for a warehouse dedicated to frozen foods.
Profitability for the year 2021/2022
The expected rate of return should be almost stable compared to the previous year due to the sustained effort on Research and Development and Sales and Marketing expenses.
Supplementary and non-IFRS Ffinancial Iinformation
The additional non-IFRS information (referred to above as EBITDA) presented in this press release is subject to inherent limitations. It is not based on any comprehensive set of accounting rules or principles and should not be considered a substitute for IFRS measures. In addition, the Company’s supplemental non-IFRS financial information may not be comparable to similarly titled non-IFRS measures used by other companies.
Next financial press release:
Publication of the 2021/2022 annual results
Its collaborative platform, Generix Supply